Barely Significant
← all phrases

“a nonsignificant trend”

5,407 sentences · 5,407 papers · 7,516 search hits before verification · confirmed specimen

Sighted at

p<0.1

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

a nonsignificant trendp = 0.0521.0× alphagold
Results indicated that the match effect on weekly symptomatic/functional impairment reduction was more pronounced for therapists who treated a higher proportion of patients with primary substance misuse or violence ( γ 101 = − 0.09, SE = 0.04, p = 0.022), though this interactive effect was only a nonsignificant trend for posttreatment symptomatic/functional impairment level ( γ 011 = − 1.20, SE = 0.60, p = 0.052).
a nonsignificant trendP = 0.0521.0× alphagold
β-cryptoxanthin demonstrated a nonsignificant trend toward the moderating effect on N2 mean amplitude during target trials ( β = −0.81, P = 0.052), whereas zeaxanthin demonstrated a marginal moderating effect on N2 target trial peak latency ( β = −0.45, P = 0.056); however, neither reached statistical significance.
a nonsignificant trendP = .0521.0× alphagold
Patient characteristics did not differ according to anesthesia techniques except that the GA group had a higher prevalence of peripheral arterial occlusive disease (PAOD) (16.0% vs 7.8%; P = .048), whereas there was a nonsignificant trend towards higher proportion of patients receiving hemodialysis in the LA group (0.7% vs 4.3%; P = .052). 3.2.
a nonsignificant trendp = 0.0521.0× alphagold
In males, sleep duration hrs was negatively related to workout strain ( r = −0.861, p = 0.001) (Figure 1 , panel A2), ExHR avg ( r = −0.757, p = 0.011) (Figure 1 , panel B2), and ExHR max ( r = −0.827, p = 0.003), and there was a nonsignificant trend between SWS hrs and ExHR avg ( r = −0.628, p = 0.052) (Figure 3 , panel A2).
a nonsignificant trendp = 0.0521.0× alphagold
After adjusting for triglyceride concentrations, the ratios apoC-III 2 /apoC-III 1 and apoC-III 0f /apoC-III 1 showed the opposite trend to that of total apoC-III in relation to apoA-I (β=-0.105, p = 0.002 for apoC-III 2 /apoC-III 1 ; β=-0.079, p = 0.024 for apoC-III 0f /apoC-III 1 ) and small HDL particles (β=-0.124, p < 0.001 for apoC-III 2 /apoC-III 1 and a nonsignificant trend for apoC-III 0f /apoC-III 1 : β=-0.075, p = 0.052), although this trend was not independent of total apoC-III.
a nonsignificant trendp = 0.0521.0× alphagold
Among treatment modalities, BTKi therapy showed a nonsignificant trend toward improved survival compared to other approaches (HR 0.29, 95% CI 0.08–1.01, p = 0.052, Table 3 ), though this finding should be interpreted cautiously given the relatively small number of patients treated with this class of agents.
a nonsignificant trendp = .0531.1× alphagold
There was also a nonsignificant trend toward a main effect of valence, F (1, 76) = 3.86, p = .053, η p 2 = .05, but no main effect due to thinking style, F (1, 76) = 0.00, p = .99, η p 2 = .00, nor any interaction of valence by thinking style, F (1, 76) = 0.00, p = .99 , η p 2 = .00, or thinking style by time, F (1, 76) = 0.95, p = .33, η p 2 = .01.
a nonsignificant trendp = 0.0531.1× alphagold
A nonsignificant trend toward an increased short-term (2.0% vs. 1.2%, RR: 1.66, 95% CI: 0.99–2.78, p = 0.053) and long-term (4.7% vs. 3.5%, incident rate ratio: 1.40, 95% CI: 0.97–2.03, p = 0.07) all-cause mortality was also found, while no differences were found in long-term (1-year) mortality neither in short- or long-term follow-up for MI, repeat revascularization, stent thrombosis, stroke, major bleeding and the composite of MACEs [ 59 ].